» Articles » PMID: 39062167

Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential

Overview
Journal Biomedicines
Date 2024 Jul 27
PMID 39062167
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The identification of clinical factors affecting the gray-scale median (GSM) and determination of GSM diagnostic utility for differentiating between symptomatic and asymptomatic internal carotid artery (ICA) stenosis.

Methods: This study included 45 patients with asymptomatic and 40 patients with symptomatic ICA stenosis undergoing carotid endarterectomy (CEA). Echolucency of carotid plaque was determined using computerized techniques for the GSM analysis. Study groups were compared in terms of clinical risk factors, coexisting comorbidities, and used pharmacotherapy.

Results: Mean GSM values in the symptomatic group were significantly lower than in the asymptomatic group ( < 0.001). Both in the univariate as well as in the multiple regression analysis, GSM was significantly correlated with D-dimers and fasting plasma glucose levels and tended to correlate with β-adrenoceptor antagonist use in the symptomatic group. In asymptomatic patients, GSM was associated with the presence of grade 2 and grade 3 hypertension, and tended to correlate with the use of metformin, sulfonylureas, and statin. Independent factors for GSM in this group remained as grade 3 hypertension and statin's therapy. The receiver operating characteristic (ROC) analysis revealed that GSM differentiated symptomatic from asymptomatic ICA stenosis with sensitivity and specificity of 73% and 80%, respectively.

Conclusion: The completely diverse clinical parameters may affect GSM in symptomatic and asymptomatic patients undergoing CEA, whose clinical characteristics were similar in terms of most of the compared parameters. GSM may be a clinically useful parameter for differentiating between symptomatic and asymptomatic ICA stenosis.

Citing Articles

The metabolism of big endothelin-1 axis and lipids affects carotid atherosclerotic plaque stability - the possible opposite effects of treatment with statins and aspirin.

Plonski A, Krupa A, Pawlak D, Sokolowska K, Sieklucka B, Gabriel M Pharmacol Rep. 2025; .

PMID: 40063220 DOI: 10.1007/s43440-025-00714-9.

References
1.
Puz P, Urbanek T, Ziaja D, Cieslik A, Steposz A, Lasek-Bal A . Factors associated with the symptomatic status of carotid artery stenosis: identification in a cross-sectional study and development of a scoring system. Pol Arch Intern Med. 2020; 131(1):17-25. DOI: 10.20452/pamw.15676. View

2.
Zhang L, Li Z, Wu Y, Fan Y, He Z, He P . Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial. Clin Ther. 2022; 44(4):482-490. DOI: 10.1016/j.clinthera.2022.02.012. View

3.
Lazar R, Wadley V, Myers T, Jones M, Heck D, Clark W . Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial. Stroke. 2021; 52(12):3855-3863. PMC: 8608701. DOI: 10.1161/STROKEAHA.120.032972. View

4.
Artom N, Montecucco F, Dallegri F, Pende A . Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. Eur J Clin Invest. 2014; 44(11):1122-34. DOI: 10.1111/eci.12340. View

5.
Howard D, van Lammeren G, Rothwell P, Redgrave J, Moll F, de Vries J . Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk. Stroke. 2014; 46(1):182-189. PMC: 4285579. DOI: 10.1161/STROKEAHA.114.007221. View